Tranzactioneaza Bicycle Therapeutics Plc Spon Ads Each Rep 1 Ord Shs (US.BCYC) - 23.61 USD (%) Tranzactioneaza

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 23.5200 USD
Ask 24.0000 USD
Minim 23.1400 USD
Maxim 23.6400 USD
Pret referinta 22.7100
Volum -
Volum ultima zi 1
Max 52 sapt 28.6701 USD
Min 52 sapt 13.1400 USD

Descriere companie

Bicycle Therapeutics plc (www.bicycletherapeutics.com) is a clinical-stage biopharmaceutical company that is developing a class of medicines for diseases. The Company is evaluating BT5528, a second-generation Bicycle Toxin Conjugate (BTC) targeting EphA2, and BT8009, a second-generation BTC targeting Nectin-4, a tumor antigen in company-sponsored Phase I/II trials. In addition, BT1718, a BTC that targets membrane type 1 matrix metalloproteinase (MT1-MMP) is being investigated in an ongoing Phase I/IIa clinical trial sponsored by the center for drug development of cancer research United Kingdom. The Company’s immune-oncology products include BT7480, BT7455 and BT7401. BT7480 is a TICA that targets CD137 and Nectin-4. BT7455 is a TICA targeting EphA2 and CD137. BT7401 is an agonistic Bicycle built from multiple CD137 monomeric Bicycles.

Informatii companie

Nume

BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS